Ex-InterMune Controller Settles SEC Suit Over Drug Tips

Former InterMune Inc. (ITMN) Controller Bruce Tomlinson settled a U.S. Securities and Exchange Commission lawsuit alleging he passed tips in 2010 about the drug Esbriet to a former business associate.

Tomlinson, who was vice president of finance and InterMune’s principal accounting officer, agreed to pay a $616,000 fine and can’t serve as an officer or director of a publicly traded company for five years, the SEC said today in a statement. He didn’t admit or deny the allegations, the agency said.

Tomlinson tipped Michael Sarkesian, a Swiss businessman, about nonpublic information on the progress of a European Union regulatory committee’s review of InterMune’s application to market Esbriet in Europe, the SEC said in a complaint filed yesterday in federal court in San Francisco. Esbriet is used to treat a fatal lung disease.

Sarkesian contacted Quorne Ltd., a British Virgin Islands-based broker whose only shareholder is a Cyprus trust maintained for the benefit of Sarkesian’s wife, to buy InterMune call options that resulted in a profit of $616,000, the SEC said.

The value of the options soared in December 2010 on news that the EU committee had approved the application. Brisbane, California-based InterMune rose 185 percent that month in trading in New York.

Sarkesian had previously resolved the matter with the SEC and was ordered to disgorge $616,000 without admitting or denying wrondgoing, the SEC said in the statement.

Colleen Mahoney, an attorney for Tomlinson, didn’t immediately return an e-mail yesterday seeking comment on the complaint.

The case is SEC v. Tomlinson, 13-02549, U.S. District Court, Northern District of California (San Francisco).

To contact the reporter on this story: Karen Gullo in San Francisco at kgullo@bloomberg.net

To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.